Gene Research

Data from meeting of the American Society of Gene Therapy highlighted

Published in Gene Therapy Weekly, July 7th, 2005

Sangamo BioSciences, Inc. (SGMO) announced highlights of data presented at the 8th Annual Meeting of the American Society of Gene Therapy (ASGT) held in St. Louis, Missouri. Sangamo scientists and their collaborators gave a total of 9 presentations related to the company's zinc finger technology.

Sangamo is developing engineered zinc finger nucleases (ZFNTM) to correct errors in the DNA sequence of disease-causing genes for so-called monogenic diseases or to disrupt genes that facilitate disease.

In a poster presentation and a Scientific Symposium Session podium presentation by Dale Ando, MD, Sangamo's vice president of therapeutic development and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-07-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry